- Supported exchanges /
- NSE /
- NECLIFE.NSE
Nectar Lifesciences Limited (NECLIFE NSE) stock market data APIs
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
Nectar Lifesciences Limited Financial Data Overview
| 32.5 | |
| 33.01 | |
| - | |
| 33.1 | |
| 32.3 | |
| 26.15-56.5 | |
| 7 845 M | |
| 74.4255 | |
| 224 M | |
| 16 493 M | |
| 1.027 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Nectar Lifesciences Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 16 493 M
- EBITDA 1 581 M
- Earnings Per Share 0.47
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Nectar Lifesciences Limited Earnings via APIs
- Latest Release 2024-11-08
- EPS/Forecast NaN
Get Nectar Lifesciences Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
